Literature DB >> 22226272

A spectrum of dynamic insulin sensitivity test protocols.

Paul D Docherty1, J Geoffrey Chase, Lisa Te Morenga, Thomas F Lotz, Juliet E Berkeley, Geoffrey M Shaw, Kirsten A McAuley, Jim I Mann.   

Abstract

BACKGROUND: Numerous tests have been developed to estimate insulin sensitivity (SI). However, most of the established tests are either too expensive for widespread application or do not yield reliable results. The dynamic insulin sensitivity and secretion test (DISST) uses assays of glucose, insulin, and C-peptide from nine samples to quantify SI and endogenous insulin secretion (UN) at a comparatively low cost. The quick dynamic insulin sensitivity test has shown that the DISST SI values are robust to significant assay omissions.
METHODS: Eight DISST-based variations of the nine-sample assay regimen are proposed to investigate the effects of assay omission within the DISST-based framework. SI and UN were identified using the fully-sampled DISST and data from 218 nine-sample tests undertaken in 74 female individuals with elevated diabetes risk. This same data was then used with appropriate assay omissions to identify SI and UN with the eight DISST-based assay variations.
RESULTS: Median intraprocedure proportional difference between SI values from fully-sampled DISST and the DISST-based variants was in the range of -17.9 to 7.8%. Correlations were in the range of r = 0.71 to 0.92 with the highest correlations between variants with the greatest commonality with the nine-sample DISST. Metrics of UN correlated relatively well between tests when C-peptide was assayed (r = 0.72 to 1) but were sometimes not well estimated when samples were not assayed for C-peptide (r = -0.14 to 0.75).
CONCLUSIONS: The DISST-based spectrum offers a series of tests with very distinct compromises of information yield, accuracy, assay cost, and clinical intensity. Thus, the spectrum of tests has the potential to enable researchers to better allocate funds by selecting an optimal test configuration for their particular application.
© 2011 Diabetes Technology Society.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22226272      PMCID: PMC3262721          DOI: 10.1177/193229681100500626

Source DB:  PubMed          Journal:  J Diabetes Sci Technol        ISSN: 1932-2968


  32 in total

Review 1.  Diagnosis, prognosis, and treatment of impaired glucose tolerance and impaired fasting glucose.

Authors:  P L Santaguida; C Balion; D Hunt; K Morrison; H Gerstein; P Raina; L Booker; H Yazdi
Journal:  Evid Rep Technol Assess (Summ)       Date:  2005-08

2.  A minimal C-peptide sampling method to capture peak and total prehepatic insulin secretion in model-based experimental insulin sensitivity studies.

Authors:  Thomas Lotz; Uli Göltenbott; J Geoffrey Chase; Paul Docherty; Christopher E Hann
Journal:  J Diabetes Sci Technol       Date:  2009-07-01

3.  Integral-based parameter identification for long-term dynamic verification of a glucose-insulin system model.

Authors:  Christopher E Hann; J Geoffrey Chase; Jessica Lin; Thomas Lotz; Carmen V Doran; Geoffrey M Shaw
Journal:  Comput Methods Programs Biomed       Date:  2005-03       Impact factor: 5.428

4.  A minimal model of insulin secretion and kinetics to assess hepatic insulin extraction.

Authors:  Gianna Toffolo; Marco Campioni; Rita Basu; Robert A Rizza; Claudio Cobelli
Journal:  Am J Physiol Endocrinol Metab       Date:  2005-09-06       Impact factor: 4.310

5.  Prediction of lean body mass from height and weight.

Authors:  R Hume
Journal:  J Clin Pathol       Date:  1966-07       Impact factor: 3.411

Review 6.  Etiology of the metabolic syndrome: potential role of insulin resistance, leptin resistance, and other players.

Authors:  P Zimmet; E J Boyko; G R Collier; M de Courten
Journal:  Ann N Y Acad Sci       Date:  1999-11-18       Impact factor: 5.691

7.  Effect of a relatively high-protein, high-fiber diet on body composition and metabolic risk factors in overweight women.

Authors:  L Te Morenga; S Williams; R Brown; J Mann
Journal:  Eur J Clin Nutr       Date:  2010-09-15       Impact factor: 4.016

8.  beta-Cell function in subjects spanning the range from normal glucose tolerance to overt diabetes: a new analysis.

Authors:  Ele Ferrannini; Amalia Gastaldelli; Yoshinori Miyazaki; Masafumi Matsuda; Andrea Mari; Ralph A DeFronzo
Journal:  J Clin Endocrinol Metab       Date:  2004-10-13       Impact factor: 5.958

Review 9.  Screening adults for type 2 diabetes: a review of the evidence for the U.S. Preventive Services Task Force.

Authors:  Russell Harris; Katrina Donahue; Saif S Rathore; Paul Frame; Steven H Woolf; Kathleen N Lohr
Journal:  Ann Intern Med       Date:  2003-02-04       Impact factor: 25.391

10.  Prehepatic insulin production in man: kinetic analysis using peripheral connecting peptide behavior.

Authors:  R P Eaton; R C Allen; D S Schade; K M Erickson; J Standefer
Journal:  J Clin Endocrinol Metab       Date:  1980-09       Impact factor: 5.958

View more
  4 in total

1.  A novel hierarchal-based approach to measure insulin sensitivity and secretion in at-risk populations.

Authors:  Paul D Docherty; J Geoffrey Chase; Lisa Te Morenga; Liam M Fisk
Journal:  J Diabetes Sci Technol       Date:  2014-05-26

Review 2.  Next-generation, personalised, model-based critical care medicine: a state-of-the art review of in silico virtual patient models, methods, and cohorts, and how to validation them.

Authors:  J Geoffrey Chase; Jean-Charles Preiser; Jennifer L Dickson; Antoine Pironet; Yeong Shiong Chiew; Christopher G Pretty; Geoffrey M Shaw; Balazs Benyo; Knut Moeller; Soroush Safaei; Merryn Tawhai; Peter Hunter; Thomas Desaive
Journal:  Biomed Eng Online       Date:  2018-02-20       Impact factor: 2.819

3.  The Effects of Additional Local-Mixing Compartments in the DISST Model-Based Assessment of Insulin Sensitivity.

Authors:  Nicholas Lam; Rua Murray; Paul D Docherty; Lisa Te Morenga; J Geoffrey Chase
Journal:  J Diabetes Sci Technol       Date:  2021-06-11

4.  Estimating Enhanced Endogenous Glucose Production in Intensive Care Unit Patients with Severe Insulin Resistance.

Authors:  Anane Yahia; Ákos Szlávecz; Jennifer L Knopp; Normy Norfiza Abdul Razak; Asma Abu Samah; Geoff Shaw; J Geoffrey Chase; Balazs Benyo
Journal:  J Diabetes Sci Technol       Date:  2021-06-02
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.